Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Jan 16.
Published in final edited form as: J Ethn Subst Abuse. 2017 Feb 15;17(4):401–419. doi: 10.1080/15332640.2016.1264337

The interactive effects of social support and physical functioning on HIV medical outcomes among African-Americans whom inject drugs

Allysha C Maragh-Bass 1, Julie A Denison 2, Roland J Thorpe Jr 1,3, Amy R Knowlton 1
PMCID: PMC6964256  NIHMSID: NIHMS1502057  PMID: 28632094

Abstract

Introduction:

Research suggests a syndemic of substance use, mental illness, and familial conflict is associated with poor HIV medical outcomes among African American persons living with HIV (PLHIV). Social support, may facilitate positive health outcomes. This study explores these correlates of HIV medical outcomes, defined as undetectable viral load (UVL) and acute care minimization.

Methods

Data were from baseline of the BEACON study (N=351). UVL was ≤40 copies/mL. Acute care minimization was no ER visits and/or hospitalizations in 6 months. Descriptive statistics, and Poisson regression was implemented (N=351).

Results:

Moderate syndemic burden was associated with viral suppression. Individuals with main partner caregivers had 35% higher likelihood of viral suppression, as individuals whose main supporters was neither kin nor main partners (Adjusted Point-Prevalence Rate Ratio [APR] = 1.35; 95% CI = 1.05, 1.74). Individuals with frequent health-related support had nearly 30 percent lower likelihood of avoiding acute care use, compared to individuals with low health-related support (APR = 0.73; 95% CI = 0.55, 0.97). Finally, interaction tests showed that physical functioning modified the relationship between main supporter type and acute care minimization.

Discussion:

Results suggest that social support receipt was not consistently associated with HIV medical outcomes. Conversely, higher syndemic burden may have facilitated positive outcomes, through necessitating increased rates of healthcare engagement. Healthcare professionals should elicit discussion of social support to strengthen PLHIVs’ and their supporters’ relationships to improve their health. Results highlight the need for culturally-tailored interventions to improve HIV medical outcomes African American PLHIV substance users.

Keywords: Healthcare utilization, Injection drug use, HIV/AIDS, Health disparities, Syndemic Theory, African Americans

INTRODUCTION

Widespread availability of antiretroviral therapy has increased life expectancy of persons living with HIV (PLHIV). Despite these advancements, only twenty-eight percent of PLHIV are aware of their status, on antiretroviral therapy (ART), and managing their illness (CDC, 2010). In a prospective study of HIV clinic patients, less than ten percent of patients were ninety-five percent adherent, which is the optimal adherence level for HIV viral suppression (Golin et al., 2002). A hospital-based clinical trial of ART adherence found patients were seventy to eighty percent adherent on average (Mannheimer, Friedland, Matts, Child, & Chesney, 2002). These rates are considerably lower among substance users; ART-adherence is estimated as low as 50 percent among injection drug users in urban areas (Arnsten et al., 2001). Previous studies have also documented adherence rates of less than seventy percent among those with serious mental illness (Wagner, Kanouse, Koegel, & Sullivan, 2003). More research is needed to understand factors associated with positive HIV medical outcomes in these populations (Wolf et al., 2007).

HIV medical outcomes among PLHIV

Extant literature identifies several key dimensions of HIV medical outcomes among PLHIV, including both viral suppression and acute care minimization. The primary biomarker of physical health among PLHIV (and of ART adherence) is viral suppression, defined as HIV viral load as less than forty copies per milliliter of blood (Aidala et al., 2016). Achievement of undetectable HIV viral load is key to slowing progression to AIDS, lowering transmission of HIV to sexual partners, and minimizing risk of HIV co-infections (Mannheimer et al., 2002; Aidala et al., 2016; Blank et al., 2015; Howe et al., 2014). Rates of viral suppression among African American substance users and/or those with mental illnesses are not well-established. Irrespective of mental illness or substance use, however, less than thirty percent of African American PLHIV are virally suppressed (CDC, 2016). Barriers to care among this population include less access to HIV testing, enrollment in primary care, and lower rates of insurance than other racial/ethnic groups (CDC, 2010; Mannheimer et al., 2002; Blank et al., 2015). More research is needed to understand medical outcomes among African Americans PLHIV, particularly if their HIV care is complicated by co-morbidities such as substance use and mental illnesses (Howe et al., 2014; Hightow-Weidman et al., 2011; Giordano et al., 2010).

The HIV Cost and Service Utilization Study defines minimization of emergency department (ED) visits, and prompt enrollment in care after HIV diagnosis as markers of successful management of HIV illness (Fremont et al., 2007). Of particular interest in the African American PLHIV population is acute care (ED) minimization, as a means of gaining insight on factors such as disease progression, physical health, and the impact of insurance status on preventable hospitalizations via engagement in outpatient and/or primary care (Billings et al., 1993). For this reason, the present study recruited individuals who were all African American substance users, publicly insured, and in HIV care. As such, “HIV medical outcomes” considers aspects of both physical health and healthcare utilization, yet is contextualized to this under-researched population.

Individual-level factors and HIV medical outcomes

Informed by a socio-ecological perspective, research suggests that individual and interpersonal-level factors may impact HIV medical outcomes (Kaufman et al., 2014; Carrico et al., 2011). Personal, or individual-level characteristics, are often associated with HIV-related health outcomes. Race- and sex-based health disparities place African Americans, particularly if they are substance users, at higher risk of poor HIV medical outcomes such as viral non-suppression than Whites and/or non-substance users (CDC, 2010; Reynolds et al., 2004). Reasons for poor HIV medical outcomes in this population may be partly due to pervasive HIV-related stigma in the African American community (Vyavaharkar et al., 2010). HIV-related stigma may impede engagement in care among PLHIV, foster medical mistrust, and may result from moral judgments and stereotypes of PLHIV (Jeffries, Marks, Lauby, Murrill, & Millet, 2013; Katz et al., 2013).

Additionally, Singer proposes that a synergistic epidemic (syndemic) refers to individual-level co-morbidities which are mutually reinforcing and increase disease burden (Singer, 1996; Singer & Clair, 2003). Subsequent studies establish substance use and mental illness as syndemic factors among PLHIV which, combined with racial disparities in HIV, place African American PLHIV at greatest risk of poor HIV medical outcomes (CDC, 2012; Ryff et al. 2006; Ware et al., 1995). However, more research is needed to understand the impact of individual-level factors on HIV medical outcomes, including syndemic factors, physical functioning, and demographics (Smit et al., 2015; Shah et al., 2015; Rai, Dutta, & Gulati, 2010; Cunningham, Crystal, Bozzette, & Hays, 2005; Levy, 1998; Barclay et al., 2007).

Interpersonal-level and HIV medical outcomes

Interpersonal-level, or socio-contextual, factors refer to norms and laws that may impede positive HIV medical outcomes (UNAIDS, 1998). Research suggests that as HIV rates increase among low-income African Americans, health-related support from social support networks may be predictive of HIV medical outcomes. Consequently, low-income African American PLHIV may rely on their social networks for health-related support, which may potentially reduce HIV-related stigma and facilitate positive health outcomes (Knowlton & Latkin, 2007; Kalichman, Cherry, & Browne-Sperling, 1999; Edwards, 2006). HIV diagnosis, substance use, and mental illness are all factors which may strain social support relationships between PLHIV and their caregivers (Robinson, Knowlton, Gielen, & Gallo, 2015). Such strain may engender familial disagreements or conflict, which may represent another syndemic-related factor contributing to poor HIV medical outcomes among low-income African Americans substance users with mental illness (Katz et al., 2013). Familial conflict may be particularly problematic for PLHIV who rely on open communication with their social support and caregivers (Robinson et al., 2015; Straus, 1979). More research is needed to understand the role social support dimensions (e.g. familial conflict, health-related support) in a highly stigmatized context.

Purpose

African American PLHIV may be at risk of poor HIV medical outcomes, due to syndemic disadvantage, HIV stigma, and poor physical functioning. Social support may mitigate these factors. Therefore, the objective of this study was to identify psychosocial correlates of HIV medical outcomes among African American PLHIV. Informed by a socio-ecological framework, we sought to: (a) identify individual and interpersonal correlates of HIV medical outcomes; and (b) assess the association between social support and HIV medical outcomes. Given the known association between social support and HIV-related health outcomes, we hypothesized that individuals with main partner supporters may be more engaged in care, and therefore less likely to utilize acute care.

METHOD

Procedure

The present study utilized data from the baseline of the Being Active and Connected (BEACON) study, which was a longitudinal project to explore pathways through which psychosocial factors and substance use influence HIV-related outcomes among HIV-positive current and former injection drug users (N=383). Inclusion criteria were: (a) age of 18 years or older; (b) HIV seropositivity; (c) current or former injection drug use; (d) use of ART in the prior month; and (e) willingness to invite supporter(s) to the study. Main participants were required to meet all inclusion criteria, were recruited by the study team. These individuals were referred to ‘Index’ participants (as opposed to main supporters whom Indexes recruited to the study themselves). Index participants were recruited mainly from an HIV clinic at a large urban teaching hospital, as well as via targeted recruitment and community sampling. Participants completed study questionnaires with trained interviewers, and were paid $35.00 per assessment. All participants (e.g. Indexes and main supporters) completed baseline (Time 1), a 6-months follow-up assessment (Time 2), and 12-months follow-up assessment (Time 3). The present study utilized data from African American Index participants only (N=351). Plasma viral load, and CD4 count data were used to verify viral suppression, and were collected at baseline and 6 month visits for all Index participants. Recall periods for survey questions ranged from one week to six months. The Johns Hopkins Bloomberg School of Public Health Institutional Review Board approved all study activities.

Measures

Dependent variables

Viral suppression was measured as ≤40 copies per mL, by the Roche Cobas Amplicor, where 0 = viral non-suppression, and 1 = viral suppression (Schumacher et al., 2007). Acute care minimization was measured by “In the past 6 months, how many times have you gone to an emergency room (ER) for your health care?”, and “In the past 6 months, how many times were you admitted to a hospital, that means that you stayed there overnight?” Responses were summed and dichotomized such that the outcome of interest was minimization of acute care (i.e. 0 = 1 or more ER visits and/or hospitalizations in the last 6 months, and 1 = none (Fremont et al., 2007; MacCallum, Zhang, Preacher, & Rucker, 2002).

Independent variables

Predictors included individual-level factors (Syndemic class, physical functioning, age, sex, education) and interpersonal-level factors (HIV stigma, negative social exchange, main supporter relationship, ART-related support, health-related support). As mentioned, syndemic factors refer to mutually-reinforcing issues which exacerbate health burden (Singer, 1996). Previous research by Robinson et al (2015) identified a syndemic of active substance use (SU), mental illness (MI), and familial conflict non-resolution (C) among this study population. Substance use was defined as reported use of opiates, marijuana, heroin, cocaine or crack, hallucinogens, and/or prescription drugs, where 0 = no substance use, 1 = use in the past month.

Mental illness was coded as reporting having ever been diagnosed with depression, bipolar disorder, anxiety or post-traumatic stress disorder, schizophrenia, and/or any other condition, where 0 = not diagnosed, and 1 = diagnosed. Familial conflict non-resolution was assessed via the Family Conflict Tactics Scale (Strauss, 1979), and was coded as family members rarely discussing problems, problem-solving together, and/or show caring for one another, where 0 = no, and 1 = yes. Previous analyses of the SUMIC Syndemic identified that greater syndemic burden was associated with poor HIV medical outcomes; however, these findings did not explore the role of social support and interpersonal-level factors with a solely African American sample (Robinson et al., 2015). In the present analyses, a 4-level categorical variable representing SUMIC syndemic classes was used, to assess its relationship to HIV medical outcomes while adjusting for multiple dimensions of social support.

Physical health (physical functioning and ADLs) was assessed by a ten-item scale based on the Medical Outcomes Study Physical Functioning Measure (McDowell & Newell, 1996). These Likert-scale items included “How much does your health affect your ability to bend, lift, or squat down?” and “How much does your health affect your ability to do moderate activities like moving a table, carrying groceries, or walking a mile?” Responses ranged from “None” to “A lot.” Responses were reverse-scored, summed, and trichotomized, where 0 = low physical functioning, 1 = moderate physical functioning, and 2 = high physical functioning; (Cronbach’s α = 0.77; Wight, Aneshensel, Murphy, Miller-Martinez, & Beals, 2006). Age was dichotomized at the median, where 0 = less than 49 years, and 1 = age 49 years and older (MacCallum et al., 2002).

Educational attainment was assessed with one item: “What is the highest level of education you’ve had?” Responses were collapsed, where 0 = 8th grade or less, 1 = some high school, 2 = high school diploma or GED, 3 = some college or above. Sex was coded as 1 = males, and 2 = females. HIV stigma was assessed via a six-item scale of items by Wight and colleagues (2006). Items included, “Thinking about having HIV, how much do you feel that you need to hide it?” and “Thinking about having HIV, how much do you fear your family will reject you?” Responses were on a 4-point Likert scale, ranging from “Not at all” to “Very much” [36]. Responses was summed and trichotomized, where 0 = low stigma, 1 = medium stigma, and 2 = high stigma (Cronbach’s α = 0.75; Fong, 2014).

Negative social exchange was assessed with items developed by Newsom and colleagues (2003). Items included, “Thinking about having HIV, how much do you feel blamed by others?” Participants’ responses were on a 3-point Likert scale, ranging from “None of the time” to “All of the time” (Newsom, Nishishiba, Morgan, Rook, & 2003). Responses were trichotomized, where 0 = low negative exchange, 1 = moderate negative exchange, and 2 = frequent negative exchange (Cronbach’s α = 0.80; Fong, 2014). Main supporter relationship was coded as 0 = Other/No main supporter/Paid supporter, 1 = main partner, and 2 = kin. Of interest was the closeness of relationship between Index and main supporter; thus, the few individuals with paid, none, or other forms of support were combined. ART-related support was assessed via one item: “How often does your main supporter talk to you about your HIV medications or side effects?” (Barrera, Jr. & Gottlieb, 1981). Responses were on a 4-point Likert scale, from “Never” to “Very often”, and trichotomized, where 0 = low ART-related support, 1 = moderate ART-related support, and 2 = high ART-related support (Fong, 2014). Health-related support was assessed with six items from the Arizona Social Support Inventory (Barrera, Jr. & Gottlieb, 1981), including “In the last year, has anyone gone with you to a doctor’s appointment or to the ER to get medical care?” Responses were dichotomized at the median, where 0 = low health-related support, and 1 = high health-related support (Cronbach’s α = 0.81; MacCullum et al., 2002).

Analyses

First, univariate frequencies were generated for all variables on the African American Index participants only, due to theoretical importance (N=351). Next, utilizing latent class analyses, study individuals were classified based on their unique patterns of SUMIC Syndemic risk. The syndemic classes were identified via latent class regression, where individuals were classified into classes based on their posterior probability of endorsing SUMIC items; these analyses are described in detail elsewhere (Robinson et al., 2015). These analyses yielded four latent classes of syndemic risk, which were applied to the present analyses using a 4-level categorical variable. Third, bivariate statistics determined which variables would remain in multivariate analyses. Marginally-significant variables (p<.10; Gordon, 2012), and/or theoretically-significant variables were entered into a Poisson regression model, which is appropriate for binary, non-rare outcomes (McNutt, Wu, Xue, & Hafner, 2003). Robust standard errors accounted for inconstant variation (Long, 1997). Finally, hypothesis testing was conducted to assess whether the role of social support on with acute care minimization outcomes. Interactions were tested between social support variables (main supporter relationship, ART-related support, health-related support) and demographic variables (sex, physical functioning). Parameter tests were conducted to assess model fit with interactive effects. Analyses were conducted on complete cases due to acceptable missingness (up to 10%; Bennett, 2001), using STATA Version 11.2 (StataCorp, 2009).

RESULTS

Descriptive statistics

Table 1 reports the demographic characteristics of all study participants (N=351). Mean age was 48.5 years (Standard Deviation = 6.0 years). Nearly half reported high rates of HIV stigma (45%), and kin main supporters (45.9%). Most participants had attended high school and/or earned a high school diploma or GED (77.2%), and were predominantly males (62.4%). Half of the participants achieved acute care minimization (51.9%). Two-thirds achieved viral suppression (66.7%). Regarding SUMIC Syndemic classes, the four syndemic classes’ prevalence were: Class 1 – Moderate Substance Use/Mental illness (43.3%); Class 2 – High Mental Illness (24.8%); Class 3 – Moderate Substance Use/Mental Illness/Familial Conflict Non-resolution (22.8%); Class 4 – High Substance Use/Mental Illness (9.1%).

Table 1.

Demographic characteristics of participants (N=351)

Demographic
Characteristic
Total
N(%) or Mean (SD)

SUMIC Syndemic class
 Moderate SU/MI (C1)   152   (43.3)
 High Mental illness (C2)   87     (24.8)
 Moderate SU/MI/C (C3)   80     (22.8)
 High Sub use/Men ill (C4)   32       (9.1)
Education
 8th grade or less   21       (6.0)
 Some high school   138   (39.3)
 High school diploma/GED   133   (37.9)
 Some college/above   59     (16.8)
HIV stigma
 Low   102   (29.1)
 Medium   91     (25.9)
 High   158   (45.0)
Negative social exchange
 Low   148   (42.2)
 Medium   116   (33.1)
 High   87     (24.8)
Health-related support
 Low   140   (39.9)
 Medium   96     (27.4)
 High   115   (32.8)
Main supporter type
 Other   80     (22.8)
 Main partner   110   (31.3)
 Kin   161   (45.9)
ART-related support
 Rarely   41     (12.4)
 Sometimes   119   (36.0)
 Often   171   (51.7)
Physical functioning
 Low   120   (34.2)
 Medium   103   (29.3)
 High   128   (36.5)
Acute care minimization
 Suboptimal   169   (48.1)
 Optimal   182   (51.9)
Viral suppression
 Detectable viral load   117   (33.3)
 Undetectable viral load   234   (66.7)
Sex
 Males   219   (62.4)
 Females   132   (37.6)
Age (years)   48.5    (6.0)

Poisson regression results: Correlates of viral suppression

In adjusted analyses, Syndemic Class 3 (Moderate SU/MI/C) had 40% higher likelihood of viral suppression as compared to Class 1 (Moderate SU/MI; Adjusted Point-Prevalence Rate Ratio [APR] = 1.38; 95% Confidence Interval [95% CI] = 1.15, 1.67; Table 2). Individuals with high physical function had 20% higher likelihood of viral suppression as those with low physical function (APR = 1.23; 95% CI = 1.01, 1.51). Individuals whose supporter was their main partner had 35% higher likelihood of viral suppression, as those whose supporter was neither kin nor a main partner (APR = 1.35; 95% CI = 1.05, 1.74; N=331). Finally, older individuals had a marginally significantly higher likelihood of viral suppression as compared to younger individuals (APR = 1.15; 95% CI = 0.97, 1.36). No differences were found by sex in likelihood of viral suppression.

Table 2.

Correlates of viral suppression - African American Indexes (N=331)

Unadjusted Adjusted

PRRa
CIc
APRb
CI
SUMIC Syndemic class
 High Mental illness (C2) 1.31** (1.10, 1.55) 1.35*** (1.12, 1.62)
 Moderate SU/MI/C (C3) 1.29** (1.09, 1.54) 1.38*** (1.15, 1.67)
 High Sub use/Men illness (C4) 0.68ǂ (0.44, 1.05) 0.81 (0.53, 1.24)
 (ref: Moderate SU/MI (C1)) 1.00 1.00
Physical functioning
 Moderate physical functioning 1.18ǂ (0.97, 1.44) 1.16 (0.96, 1.40)
 High physical functioning 1.25* (1.04, 1.50) 1.23* (1.01, 1.51)
 (ref: Low physical functioning) 1.00 1.00
HIV stigma
 Moderate stigma 0.99 (0.81, 1.21) 0.96 (0.78, 1.18)
 High stigma 1.01 (0.84, 1.20) 1.01 (0.84, 1.22)
 (ref: Low stigma) 1.00 1.00
Education
 Some high school 1.49 (0.89, 2.47) 1.52ǂ (0.93, 2.48)
 High school diploma/GED 1.61ǂ (0.97, 2.68) 1.52ǂ (0.93, 2.47)
 Some college or above 1.78* (1.06, 2.98) 1.72* (1.04, 2.85)
 (ref: 8th grade or less) 1.00 1.00
Negative social exchange
 Medium exchange 1.02 (0.86, 1.20) 1.05 (0.88, 1.24)
 High exchange 0.92 (0.75, 1.12) 1.02 (0.82, 1.28)
 (ref: Low exchange) 1.00 1.00
Main supporter relationship
 Main partner 1.11 (0.90, 1.37) 1.35* (1.05, 1.74)
 Kin 1.08 (0.88, 1.31) 1.27* (1.00, 1.62)
 (ref: Other/No supporter) 1.00 1.00
ART-related support
 Sometimes 0.91 (0.74, 1.13) 0.85 (0.69, 1.04)
 Often 0.82ǂ (0.66, 1.01) 0.79* (0.64, 0.97)
 (ref: Rarely) 1.00 1.00
Health-related support
 Medium support 1.16ǂ (0.98, 1.36) 1.16ǂ (0.97, 1.39)
 High support 0.91 (0.75, 1.11) 1.00 (0.82, 1.23)
 (ref: Low support) 1.00 1.00
Age (49 years & up) 1.12 (0.96, 1.30) 1.15ǂ (0.97, 1.36)
Sex (Females) 0.98 (0.84, 1.15) 1.07 (0.91, 1.27)
ǂ

marginally significant p<.10,

*

p<.05,

**

p<.01,

***

p<.001

a

PRR = Point-Prevalence Rate Ratio

b

APR = Adjusted Point-Prevalence Rate Ratio

c

CI = 95% Confidence Interval

Poisson regression results: Correlates of acute care minimization

In adjusted analyses, individuals in Classes 2 (High MI) and 4 (High SU/MI) had between 30 to 70% lower likelihood of acute care minimization (e.g. were more likely to use acute care; Table 3 Model 1). Individuals with frequent ART-related support had 26% lower likelihood of acute care minimization as compared to individuals reporting rare ART-related support (APR = 0.74; 95% CI = 0.57, 0.95). Individuals with frequent health-related support had 30% lower likelihood of acute care minimization as individuals with low health-related support (APR = 0.73; 95% CI = 0.55, 0.97). No differences were found by age or sex in likelihood of acute care minimization.

Table 3.

Correlates of acute care minimization - African American Indexes (N=331)

Unadjusted Model 1d Model 2e

PRRa
CIc
APRb
CI
APR
CI
SUMIC Syndemic class
 High Mental illness (C2) 0.63** (0.47, 0.84) 0.66** (0.48, 0.89) 0.63** (0.46, 0.86)
 Moderate SU/MI/C (C3) 1.05 (0.85, 1.30) 1.10 (0.87, 1.38) 1.03 (0.82, 1.30)
 High Sub use/Men ill (C4) 0.31** (0.15, 0.65) 0.35** (0.16, 0.77) 0.34** (0.16, 0.72)
 (ref: Moderate SU/MI (C1)) 1.00 1.00 1.00
ART-related support
 Sometimes 0.89 (0.68, 1.17) 0.89 (0.70, 1.13) 0.93 (0.73, 1.18)
 Often 0.65** (0.49, 0.86) 0.74* (0.57, 0.95) 0.77* (0.60, 1.00)
 (ref: Rarely) 1.00 1.00 1.00
HIV stigma
 Moderate stigma 0.93 (0.72, 1.20) 0.92 (0.72, 1.18) 0.94 (0.74, 1.20)
 High stigma 0.81ǂ (0.64, 1.02) 0.83 (0.66, 1.05) 0.87 (0.69, 1.09)
 (ref: Low stigma) 1.00 1.00 1.00
Education
 Some high school 0.91 (0.59, 1.42) 1.08 (0.70, 1.66) 1.04 (0.68, 1.59)
 High school diploma/GED 1.08 (0.70, 1.66) 1.23 (0.81, 1.88) 1.19 (0.79, 1.81)
 Some college or above 0.97 (0.60, 1.57) 1.17 (0.72, 1.88) 1.07 (0.66, 1.74)
 (ref: 8th grade or less) 1.00 1.00 1.00
Negative social exchange
 Medium exchange 0.94 (0.74, 1.20) 0.87 (0.69, 1.11) 0.86 (0.68, 1.08)
 High exchange 1.06 (0.83, 1.35) 1.07 (0.83, 1.38) 1.05 (0.81, 1.35)
 (ref: Low exchange) 1.00 1.00 1.00
Health-related support
 Medium support 0.76* (0.60, 0.97) 0.83 (0.66, 1.06) 0.83 (0.66, 1.05)
 High support 0.61*** (0.47, 0.79) 0.73* (0.55, 0.97) 0.70* (0.53, 0.93)
 (ref: Low Support) 1.00 1.00 1.00
Sex (Females) 0.90 (0.73, 1.12) 1.11 (0.88, 1.39) 1.14 (0.90, 1.44)
Age (49 years & older) 1.14 (0.93, 1.40) 1.12 (0.91, 1.39) 1.11 (0.89, 1.37)
Physical functioning
 Medium physical function. 1.60** (1.19, 2.14) 1.53** (1.14, 2.07) ---
 High physical functioning 1.74*** (1.33, 2.30) 1.45** (1.08, 1.94) ---
 (ref: Low physical function.) 1.00 1.00 ---
Main supporter relationship
 Main partner 0.93 (0.71, 1.23) 1.09 (0.80, 1.49) ---
 Kin 0.97 (0.74, 1.25) 1.05 (0.80, 1.38) ---
 (ref: Other/No supporter) 1.00 1.00 ---
Phys func × Main supporter
Low phys func × Partner 1.59 (0.69, 3.66)
Low phys func × Kin 1.32 (0.61, 2.86)
Med phys func × Other 1.33 (0.54, 3.27)
Med phys func × Partner 2.13ǂ (0.99, 4.59)
Med phys func × Kin 2.20* (1.05, 4.61)
High phys func × Other 2.49* (1.19, 5.19)
High phys func × Partner 1.83 (0.87, 3.85)
High phys func × Kin 1.72 (0.83, 3.55)
(ref: Low phys func × Other) 1.00
ǂ

marginally significant p<.10,

*

p<.05,

**

p<.01,

***

p<.001

a

PRR = Point-Prevalence Rate Ratio

b

APR = Adjusted Point-Prevalence Rate Ratio

c

CI = 95% Confidence Interval

d

=Main effects model

e

=Model with main effects and interaction term (Main supporter×Physical Functioning)

Hypothesis testing

We hypothesized that individuals with main partner supporters may be more engaged in care, and therefore less likely to utilize acute care. Interactions were tested between social support variables (main supporter relationship, ART-related support, health-related support) and demographic variables (sex, physical functioning). We found that physical functioning modified the relationship between main supporter type and acute care minimization. A parameter test of the interaction term was marginally-significant (Chi-square statistic [χ2] = 9.00; p=.06; Ai & Norton, 2003). Model 2 reports a categorical variable, denoting each of the nine variable combinations (e.g. 1 = Low physical functioning and Main supporter is non-kin and non-partner). While traditional interactive effects are demonstrated by stratifying by variable levels, the present analyses replicated an approach by Gaskin and colleagues (2014), whereby a categorical variable denoted each of the nine interaction variable combinations, in order to simultaneously interpret main and interactive effects. Thus, in Model 2 in Table 3 details a single categorical variable, differentiating combined main and interactive effects by level (Gaskin et al., 2014). Compared to those with low physical functioning, individuals with high functioning and an “Other” supporter had 2.5 times the likelihood of acute care minimization (APR = 2.49; 95% CI = 1.19, 5.19). Figure 1 depicts marginal effects of the interaction on probability of acute care minimization, holding all other covariates at their means (N=331; StataCorp, 2009). Probability of acute care minimization was highest for individuals with high physical functioning and an “Other” supporter, and lowest for those with low physical functioning and an “Other” supporter (0.67 vs. 0.27, respectively).

Figure 1.

Figure 1.

Marginal effects depicting interaction of physical functioning on association between main supporter relationship and acute care minimization among African American Indexes (N=331)

DISCUSSION

The purpose of the present study was to assess HIV medical outcomes among African American PLHIV whom inject drugs. Informed by social-ecological model, the present study was unique in its assessment of individual and interpersonal factors which impact HIV medical outcomes, among an under-researched population. The present study population was low-income, African American, with a history of syndemic substance use, mental illness, and familial conflict non-resolution. Study findings suggest that all of these factors function uniquely in their associations with HIV medical outcomes. This is congruent with the HIV literature, as PLHIV have complex personal and socio-contextual characteristics impacting their health. Mechanisms which may explain these relationships, however, differ by HIV medical outcome (Tables 3 and 4).

Surprisingly, we found that individuals with moderate SUMIC Syndemic burden (Class 3) had 1.4 times the likelihood of viral suppression as individuals with low syndemic burden (Class 1). It is possible that higher rates of concurrent substance use and mental illness requires more engagement in healthcare, thereby promoting consistent use of HIV medications and facilitating viral suppression. Given that the main difference between the classes was higher presence of familial conflict non-resolution in Class 3, future research should explore factors associated with familial conflict non-resolution, healthcare engagement, and medical outcomes (Robinson et al., 2015).

Highly physically functioning individuals had a twenty percent higher likelihood of viral suppression as low physically functioning individuals, which is consistent with previous research among PLHIV (Cunningham et al., 2005). Higher education was also associated with increased likelihood of viral suppression; thus, healthcare providers should address educational and/or literacy factors among African American PLHIV (Osborn, Paasche-Orlow, Davis, & Wolf, 2007). Individuals with kin or main partner supporters had higher likelihood of viral suppression, suggesting that social supporters are critical to engage in health interventions (Mosack & Petroll, 2009). Correlates of acute care minimization included physical functioning, main supporter relationship, and SUMIC Syndemic class. Contrary to viral suppression, and as expected, higher SUMIC Syndemic burden predicted lower likelihood of acute care minimization, which is consistent with previous HIV health services research (Meyer, Springer, & Altice, 2011). A novel finding was that higher levels of health-related support was associated with lower likelihood of acute care minimization. It is possible health-related support is being provided to PLHIV, without clear communication about expectations with main supporters, particularly if these Indexes are also in poor physical health.

Hypothesis testing revealed that physical functioning modified the relationship between main supporter type and acute care minimization (Table 3 and Figure 1). Research suggests that highly physically-functional individuals should have had the least reason to utilize acute care; yet, this was only true for individuals with non-kin and non-partner supporters. For all other levels of physical functioning, having a kin or partner supporter promoted acute care utilization. Thus, this finding suggests that a complicated relationship exists when partners or kin are main supporters. It is plausible that these individuals may worry more about participants, and show caring by encouraging their use of acute care services more than other caregivers.

Limitations

This study has several limitations. First, data were cross-sectional, which prevents assessment of causality. Second, other correlates may have merited inclusion in statistical models, such as psychiatric medication adherence, which many participants reported using. Third, participants were African Americans whom inject drugs, were enrolled in medical care, and on HIV medication. While this population is underrepresented in research, findings may differ by race/ethnic groups, or among African Americans who live in suburban/rural areas. Next, acute care minimization was an outcome of interest, yet it is possible that individuals were using acute care services appropriately, for issues that could not have been managed with primary care. Last, the marginal significance of the interaction between main supporter type and level of physical functioning on acute care minimization may be because interactions are less powered than main effects. While the term was retained for theoretical meaning (Greenland, 1993), future research should investigate this relationship with a larger sample.

Nonetheless, the present study has several strengths. This study simultaneously examined multiple socio-ecological levels of correlates of HIV medical outcomes (individual and interpersonal). To date, latent class syndemic analysis and secondary HIV prevention has only been evaluated in four previous studies (Robinson et al., 2015; Blashill et al., 2014; Mizuno et al., 2015; Sullivan, Messer, & Quinlivan, 2015). Next, HIV medical outcomes, defined as both viral suppression and acute care minimization comprises a nuanced, contextualized definition of HIV health outcomes, in a study population of mostly-insured PLHIV with access to primary and HIV specialty care. Moreover, this study was the first to apply the newly defined SUMIC Syndemic to assess among different dimensions of HIV health outcomes among a completely African American sample (Robinson et al., 2015). The present also applied novel statistical analyses of syndemic classes, by using class membership as a categorical predictor in regression analyses. Finally, study analyses found a novel interactive effect between physical functioning and type of supportive relationship, and investigated this finding with a new statistical approach (Gaskin et al., 2014).

Conclusions

This study supports the importance of examining syndemic factors as correlates of HIV medical outcomes. Even among individuals enrolled in HIV primary care, on ART, and covered by health insurance, use of emergency (acute) health care was still high (48%). The surprising relationship between health-related support and acute care minimization, and interaction between main supporter and physical functioning on acute care minimization, suggest that interpersonal-level factors may be important for acute care minimization. Moreover, post-hoc SUMIC Syndemic analyses show that nearly seventy percent of the class with highest burden were females. Therefore, it is possible that socio-context may differ by sex. African American females may have more familial and financial demands on them and less access to social support, in addition to increased HIV prevalence (Vyavaharkar et al., 2010). Reynolds et al., (2004) and Schneider, Kaplan, Greenfield, Li, and Wilson (2004) found interventions to increase self-efficacy among African-American females were predictive of increased ART adherence and increased engagement in care with HIV health care providers. Future health programs should specifically target African-American women, and include activities to increase their health self-efficacy.

Findings suggest that contrary to existing HIV literature, social support was not a clear correlate of both viral suppression and minimization of acute care use among African American PLHIV whom inject drugs. This research supports the need for continued prioritization of research to understand the social supportive care needs of low-income African American PLHIV, whom represent a vulnerable population at risk of poor HIV health outcomes (Knowlton & Latkin, 2007; Kalichman, Cherry, & Browne-Sperling, 1999; Edwards, 2006).

Moreover, given the level of syndemic substance use, mental illness, and familial conflict non-negotiation in our study sample, positive health outcomes may be facilitated by integrated mental healthcare in HIV primary care. Zea, Reisen, Poppen, Bianchi, and Echeverry (2005), Rotheram-Borus et al. (2011) and Tolle (2009) cite integrated HIV and family therapy as reducing rates of mental illness and substance use among participants, irrespective of age and/or type of familial conflict (e.g. inter-spousal disagreement, parent-child, sibling). Encouragingly, the Affordable Care Act has expanded coverage of mental illness and substance abuse treatment (Beronio, Po, Skopec, & Glied, 2013). However, future programs must consider the unique needs of African American women, who are becoming the new face of HIV/AIDS in the United States and have less access to care, irrespective of insurance status (CDC, 2010).

Medical mistrust is a long-standing factor which has been associated with poor health outcomes among African Americans; existing literature also supports cross-cultural medical education as a means to reduce aforementioned HIV disparities experienced in this population (Saha et al., 2013). As such, healthcare provider education may serve as a crucial pathway to improving outcomes among these individuals. A possible intervention may be with healthcare providers, to train them in skills beyond cultural competence via implementation of structural competence training (Metzl & Hansen, 2014). While closely related to cultural competency, structural competence acknowledges health-related factors beyond patient ethnicity, such as food access, institutional racism, and political infrastructure (Metzl & Hansen, 2014). This type of training may better prepare providers to understand the etiology of syndemic factors in PLHIV patients, as well as the larger impact of structural factors such as wealth disparities.

Finally, this study tested statistical models to assess two dimensions of HIV medical outcomes. The generalizability of these differing effects of SUMIC Syndemic class on viral suppression (HIV health biomarker) and acute care minimization (healthcare utilization) should be addressed by future studies, with other racial/ethnic and/or non-substance using PLHIV populations. The importance of mental and physical health in HIV medical outcomes merit further research to improve the health and quality of life among African Americans whom inject drugs.

ACKNOWLEDGEMENTS

This study was supported by grants from the National Institutes of Health (R01 DA019413 and R01 NR14050–01). This research was also supported by the Johns Hopkins Center for AIDS Research (1P30AI094189).

Footnotes

Conflicts of interest: None

REFERENCES

  1. Ai C, Norton EC (2003). Interaction Terms in Logit and Probit Models. Economics Letters, 80(1), 123–9. [Google Scholar]
  2. Aidala AA, Wilson MG, Shubert V, Gogolishvili D, Globerman J, Rueda S, Bozack AK, Caban M, & Rourke SB (2016). Housing Status, Medical Care, and Health Outcomes Among People Living With HIV/AIDS: A Systematic Review. American Journal of Public Health, 106(1):95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, Chang CJ, Buono D, Eckholdt H, Howard AA, Schoenbaum EE (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clinical Infectious Disease, 33(8):1417–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, Levine AJ, Durvasula RS (2007). Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychology, 26, 40–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barrera MA Jr., Gottlieb BH (1981). Social Support in the adjustment of pregnant adolescents: Assessment issues. In Gottlieb BH (Ed.). Social networks and social support, 69–96. [Google Scholar]
  6. Bennett DA (2001). How can I deal with missing data in my study? Australian and New Zealand Journal of Public Health, 25, 464–9. [PubMed] [Google Scholar]
  7. Beronio K, Po R, Skopec L, Glied S. Will Expand Mental Health and Substance Use Disorder Benefits and Parity Protections for 62 Million Americans ASPE Research Brief: Affordable Care Act. Retrieved July 16, 2016 from http://aspe.hhs.gov/health/reports/2013/mental/rb_mental.pdf. 2013. [Google Scholar]
  8. Billings J, Zeitel L, Lukomnik J, Carey TS, Blank AE, & Newman L. (1993). Impact of socioeconomic status on hospital use in New York City. Health affairs, 12(1), 162–173. [DOI] [PubMed] [Google Scholar]
  9. Blank AE, Fletcher J, Verdecias N, et al. , (2015). Factors associated with retention and viral suppression among a cohort of HIV+ women of color. AIDS Patient Care & STDS, 29(S1) :S27–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Blashill AJ, Bedoya CA, Mayer KH, O’Cleirigh C, Pinkston MM, Remmert JE, Mimiaga MJ, Safren SA (2014). Psychosocial Syndemics are Additively Associated with Worse ART Adherence in HIV-Infected Individuals. AIDS & Behavior, (Epub), doi: 10.1007/s10461-014-0925-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Carrico AW, Bangsberg DR, Weiser SD, Chartier M, Dilworth SE, & Riley ED (2011). Psychiatric correlates of HAART utilization and viral load among HIV-positive impoverished persons. AIDS (London, England), 25(8), 1113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Centers for Disease Control and Prevention [CDC] (2010). HIV/AIDS and women: For the public. Retrieved August 1, 2016 from http://www.cdc.gov/hiv/topics/women/index.htm.
  13. CDC. (2012). Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. dependent areas. HIV Surveillance Supplement Report. 2010; 17(3A), 1–20. [Google Scholar]
  14. CDC (2016). HIV Among African Americans. Retrieved November 1, 2016 from http://www.cdc.gov/hiv/pdf/group/racialethnic/africanamericans/cdc-hiv-africanamericans.pdf
  15. Cunningham WE, Crystal S, Bozzette S, Hays RD (2005). The Association of Health-related Quality of Life with Survival Among Persons with HIV Infection in the United States. Journal of General Internal Medicine, 21–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Edwards LV (2006). Perceived Social Support and HIV/AIDS Medication Adherence Among African-American Women. Qualitative Health Research, 16, 679–91. [DOI] [PubMed] [Google Scholar]
  17. Fong Y. (2014). R Statistical Software – Chngpt package for change point logistic regression. Retrieved July 17, 2016 from http://www.cran.r.project.org/web/packages/chngpt/chngpt.pdf.
  18. Fremont A, Young A, Chinman M, Pantoja P, Morton SC, Koegel P, Sullivan JG, Kanouse DE (2007). Differences in HIV Care Between Patients with and Without Severe Mental Illness. Psychiatric Services, 58(5), 681–8. [DOI] [PubMed] [Google Scholar]
  19. Gaskin DJ, Thorpe RJ Jr., McGinty EE, Bower K, Rohde C, Young JH, LaVeist TA, Dubay L. (2014). Disparities in Diabetes: The Nexus of Race, Poverty, and Place. American Journal of Public Health, 104(11):2147–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Giordano TP, Bartsch G, Zhang Y, Tedaldi E, Absalon J, Mannheimer S, … & MacArthur RD (2010). Disparities in outcomes for African American and Latino subjects in the flexible initial retrovirus suppressive therapies (FIRST) trial. AIDS patient care and STDs, 24(5), 287–295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Golin CE, Liu H, Hays RD, Miller LG, Beck CK, Ickovics J, Kaplan AH, Wenger NS (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17(10):756–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gordon RA (2012). Applied Statistics for the Social and Health Sciences. New York, NY: Routledge. [Google Scholar]
  23. Greenland S. (1993). Basic Problems in Interaction Assessment. Environmental Health Perspectives, 101(S4), 59–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hightow-Weidman LB, Jones K, Phillips G, Wohl A, & Giordano, for The YMSM of Color SPNS Initiative Study Group, T. P. (2011). Baseline clinical characteristics, antiretroviral therapy use, and viral load suppression among HIV-positive young men of color who have sex with men. AIDS Patient Care and STDs, 25(S1), S9–S14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Howe CJ, Cole SR, Napravnik S, et al. (2014). The role of at-risk alcohol/drug use and treatment in appointment attendance and virologic suppression among HIV(+) African Americans. AIDS Research and Human Retroviruses, 30(3):233–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Howe CJ, Napravnik S, Cole SR, Kaufman JS, Adimora AA, Elston B, & Mugavero MJ (2014). African American race and HIV virological suppression: Beyond disparities in clinic attendance. American Journal of Epidemiology, 179(12):1484–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jeffries IV WL, Marks G, Lauby J, Murrill CS, Millett GA (2013). Homophobia is associated with sexual behavior that increases risk of acquiring and transmitting HIV infection among black men who have sex with men. AIDS & Behavior, 17(4), 1442–53. [DOI] [PubMed] [Google Scholar]
  28. Joint United Nations Programme on HIV/AIDS (1998). Expanding the global response to HIV/AIDS through focused action: Reducing risk and vulnerability: definitions, rationale and pathways. Geneva, UNAIDS. [Google Scholar]
  29. Kalichman SC, Cherry C, Browne-Sperling F. (1999). Effectiveness of a video-based motivational skills-building HIV risk-reduction intervention for inner-city African American men. Journal of Consulting & Clinical Psychology, 67, 959–66. [DOI] [PubMed] [Google Scholar]
  30. Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, & Tsai AC (2013). Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. Journal of the International AIDS Society, 16(3). [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kaufman MR, Cornish F, Zimmerman RS, & Johnson BT (2014). Health behavior change models for HIV prevention and AIDS care: practical recommendations for a multi-level approach. Journal of Acquired Immune Deficiency Syndromes, (S3), S250–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Knowlton AR, Latkin CA (2007). Network financial support and conflict as predictors of depressive symptoms among a highly disadvantaged population. Journal of Community Psychology, 35(1), 13–28. [Google Scholar]
  33. Levy JA (1998). HIV/AIDS and injecting drug use in later life. Research & Aging, 20, 776–97. [Google Scholar]
  34. Long JS (1997). Regression Models for Categorical and Limited Dependent Variables – Advanced Quantitative Techniques in the Social Sciences. (1st ed). Thousand Oaks, CA: Sage Publications. [Google Scholar]
  35. MacCallum RC, Zhang S, Preacher KJ, Rucker DD (2002). On the Practice of Dichotomization of Quantitative Variables. Psychological Methods, 7(1), 19–40. [DOI] [PubMed] [Google Scholar]
  36. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. (2002). The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical & Infectious Diseases, 34(8), 1115–21. [DOI] [PubMed] [Google Scholar]
  37. McDowell I, Newell C. (1996). Measuring Health. (2nd ed.). New York, NY: Oxford. [Google Scholar]
  38. McNutt LA, Wu C, Xue X, Hafner JP (2003). Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes. American Journal of Epidemiology, 157(10), 940–3. [DOI] [PubMed] [Google Scholar]
  39. Metzl JM, Hansen H. (2014). Structural competency: Theorizing a new medical engagement with stigma and inequality. Social Science & Medicine, 103, 126–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Meyer JP, Springer SA, Altice FL (2011). Substance abuse, violence, and HIV in women: a literature review of the syndemic. Journal of Women’s Health, 20(7), 991–1006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Mosack KE, Petroll A, (2009). Patients’ Perspectives on Informal Caregiver Involvement in HIV Health Care Appointments. AIDS Patient Care& STDS, 23(12), 1043–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Mizuno Y, Purcell DW, Knowlton AR, Wilkinson JD, Gourevitch MN, & Knight KR (2015). Syndemic vulnerability, sexual and injection risk behaviors, and HIV continuum of care outcomes in HIV-positive injection drug users. AIDS & Behavior, 19(4):684–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Newsom JT, Nishishiba M, Morgan DL, Rook KS (2003). The relative importance of three domains of positive and negative social exchanges: A longitudinal model with comparable measures. Psychology & Aging, 18,746–54. [DOI] [PubMed] [Google Scholar]
  44. Osborn CY, Paasche-Orlow MK, Davis TC, Wolf MS (2007). Health literacy: an overlooked factor in understanding HIV health disparities. American Journal of Preventive Medicine, 33, 374–8. [DOI] [PubMed] [Google Scholar]
  45. Rai Y, Dutta T, Gulati AK (2010). Quality of life of HIV-infected people across different stages of infection. Journal of Happiness Studies, 11(1), 61–9. [Google Scholar]
  46. Reynolds NR, Testa MA, Marc LG, Chesney MA, Neidig JL, Smith SR, Vella S, Robbins GK (2004). Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study. AIDS & Behavior, 8(2), 141–50. [DOI] [PubMed] [Google Scholar]
  47. Robinson AC, Knowlton AR, Gielen AC, Gallo JJ (2015). Substance use, mental illness, and familial conflict non-negotiation among HIV-positive African-Americans: latent class regression and a new syndemic framework. Journal of Behavioral Medicine, 39(1), 1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Rotheram-Borus MJ, Swendeman D, Lee S, Li L, Amani B, Nartey M. (2011). Interventions for families affected by HIV. Translational Behavioral Medicine, 1(2), 313–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Ryff CD, Love GD, Urry LH, Muller D, Rosenkranz MA, Friedman EM, Davidson RJ, Singer B. (2006). Psychological well-being and ill-being: do they have distinct or mirrored biological correlates? Psychotherapy & Psychosomatics, 75, 85–95. [DOI] [PubMed] [Google Scholar]
  50. Saha S, Korthuis PT, Cohen JA, Sharp VL, Moore RD, Beach MC (2013). Primary care provider cultural competence and racial disparities in HIV care and outcomes. Journal of General Internal Medicine, 28, 622–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB (2004). Better physician patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. Journal of General Internal Medicine, 19, 1096–1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Schumacher WE, Frick M, Kauselmann V, Maier-Hoyle R, van der Vliet R, Babiel R. (2007). Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS Taqman system. Journal of Clinical Virology, 38, 304–12. [DOI] [PubMed] [Google Scholar]
  53. Shah K, McMahon JM, Trabold N, Aidala AA, Chen M, Pouget ER, Klostermann K. (2015). Determinants of physical and global functioning in adult HIV-positive heterosexual men. AIDS Care, 27(9), 1079–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Singer M. (1996). A Dose of Drugs, a Touch of Violence, a Case of AIDS: Conceptualizing the SAVA Syndemic. Free Inquiry in Creative Sociology, 24(2), 99–110. [Google Scholar]
  55. Singer M, Clair S. (2003). Syndemics and public health: reconceptualizing disease in bio-social context. Medical Anthropology Quarterly, 17(4), 423–41. [DOI] [PubMed] [Google Scholar]
  56. Straus MA (1979). Measuring intra family conflict and violence: The Conflict Tactics (CT) Scales. Journal of Marriage & the Family, 41(1), 75–88. [Google Scholar]
  57. Smit E, Wanke C, Dong K, Grotheer A, Hansen S, Skinner S, & Tang AM (2015). Frailty, Food Insecurity, and Nutritional Status in People Living with HIV. The Journal of Frailty & Aging, 4(4), 191–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Sullivan KA, Messer LC, Quinlivan EB (2015). Substance Abuse, Violence, and HIV/AIDS (SAVA) Syndemic Effects on Viral Suppression Among HIV Positive Women of Color. AIDS Patient Care & STDs,29(S1): S42–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. StataCorp (2009). Stata 11 Base Reference Manual. College Station, TX: Stata Press. [Google Scholar]
  60. StataCorp (2009). Stata Statistical Software: Rel. 11 College Station, TX: StataCorp, LP. [Google Scholar]
  61. Tolle M. (2009). A package of primary health care services for comprehensive family centered HIV/AIDS care and treatment programs in low income settings. Tropical Medicine & International Health, 14(6), 663–72. [DOI] [PubMed] [Google Scholar]
  62. Vyavaharkar M, Moneyham L, Corwin S, Saunders R, Annang L, & Tavakoli A. (2010). Relationships between stigma, social support, and depression in HIV-infected African American women living in the rural Southeastern United States. Journal of the Association of Nurses in AIDS Care, 21(2), 144–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wagner GJ, Kanouse DE, Koegel P, Sullivan G. (2003). Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care & STDS, 17(4):179–86. [DOI] [PubMed] [Google Scholar]
  64. Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. (1995). Comparison of Methods for Scoring and Statistical Analysis of SF-36 Health Profiles and Summary Measures: Summary of Results from the Medical Outcomes Study. Medical Care, 33(S4), AS264–79. [PubMed] [Google Scholar]
  65. Wight RG, Aneshensel CS, Murphy DA, Miller-Martinez D, Beals KP (2006). Perceived HIV stigma in AIDS caregiving dyads. Social Science & Medicine, 62(2), 444–56. [DOI] [PubMed] [Google Scholar]
  66. Wolf MS, Davis TC, Osborn CY, Skripkauskas S, Bennett CL, Makoul G. (2007). Literacy, self-efficacy, and HIV medication adherence. Patient Education & Counseling, 65(2), 253–60. [DOI] [PubMed] [Google Scholar]
  67. Zea M, Reisen C, Poppen P, Bianchi F, Echeverry J. (2005). Disclosure of HIV status and psychological well-being among Latino gay and bisexual men. AIDS & Behavior, 9(1), 15–26. [DOI] [PubMed] [Google Scholar]

RESOURCES